145 related articles for article (PubMed ID: 32515910)
1. Prospective, controlled, blinded, randomized crossover trial evaluating the effect of maropitant versus ondansetron on inhibiting tranexamic acid-evoked emesis.
Kantyka ME; Meira C; Bettschart-Wolfensberger R; Hartnack S; Kutter APN
J Vet Emerg Crit Care (San Antonio); 2020 Jul; 30(4):436-441. PubMed ID: 32515910
[TBL] [Abstract][Full Text] [Related]
2. Anti-nausea effects and pharmacokinetics of ondansetron, maropitant and metoclopramide in a low-dose cisplatin model of nausea and vomiting in the dog: a blinded crossover study.
Kenward H; Elliott J; Lee T; Pelligand L
BMC Vet Res; 2017 Aug; 13(1):244. PubMed ID: 28814338
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of orally administered maropitant and ondansetron in preventing preoperative emesis and nausea in healthy dogs premedicated with a combination of hydromorphone, acepromazine, and glycopyrrolate.
Burke JE; Hess RS; Silverstein DC
J Am Vet Med Assoc; 2021 Dec; 260(S1):S40-S45. PubMed ID: 34914630
[TBL] [Abstract][Full Text] [Related]
4. Effects of maropitant, acepromazine, and electroacupuncture on vomiting associated with administration of morphine in dogs.
Koh RB; Isaza N; Xie H; Cooke K; Robertson SA
J Am Vet Med Assoc; 2014 Apr; 244(7):820-9. PubMed ID: 24649993
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of orally administered maropitant citrate in preventing vomiting associated with hydromorphone administration in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 May; 244(10):1164-9. PubMed ID: 24786163
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of maropitant in the prevention of delayed vomiting associated with administration of doxorubicin to dogs.
Rau SE; Barber LG; Burgess KE
J Vet Intern Med; 2010; 24(6):1452-7. PubMed ID: 21039869
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of metoclopramide, ondansetron and maropitant in preventing parvoviral enteritis-induced emesis in dogs.
Yalcin E; Keser GO
J Vet Pharmacol Ther; 2017 Dec; 40(6):599-603. PubMed ID: 28198032
[TBL] [Abstract][Full Text] [Related]
8. Effect of dosing interval on efficacy of maropitant for prevention of hydromorphone-induced vomiting and signs of nausea in dogs.
Hay Kraus BL
J Am Vet Med Assoc; 2014 Nov; 245(9):1015-20. PubMed ID: 25313812
[TBL] [Abstract][Full Text] [Related]
9. Ondansetron in dogs with nausea associated with vestibular disease: A double-blinded, randomized placebo-controlled crossover study.
Henze L; Foth S; Meller S; Twele F; Charalambous M; Kenward H; Elliott J; Pelligand L; Volk HA
J Vet Intern Med; 2022 Sep; 36(5):1726-1732. PubMed ID: 35906792
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs.
Sedlacek HS; Ramsey DS; Boucher JF; Eagleson JS; Conder GA; Clemence RG
J Vet Pharmacol Ther; 2008 Dec; 31(6):533-7. PubMed ID: 19000276
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of maropitant in preventing vomiting in dogs premedicated with hydromorphone.
Hay Kraus BL
Vet Anaesth Analg; 2013 Jan; 40(1):28-34. PubMed ID: 23082784
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs.
Benchaoui HA; Siedek EM; De La Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Vet Rec; 2007 Sep; 161(13):444-7. PubMed ID: 17906225
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the antiemetic efficacy of maropitant in dogs medicated with morphine and acepromazine.
Lorenzutti AM; Martín-Flores M; Litterio NJ; Himelfarb MA; Zarazaga MP
Vet Anaesth Analg; 2016 Mar; 43(2):195-8. PubMed ID: 26095960
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of maropitant for treatment and prevention of emesis caused by intravenous infusion of cisplatin in dogs.
de la Puente-Redondo VA; Tilt N; Rowan TG; Clemence RG
Am J Vet Res; 2007 Jan; 68(1):48-56. PubMed ID: 17199418
[TBL] [Abstract][Full Text] [Related]
15. Effects of maropitant citrate or acepromazine on the incidence of adverse events associated with hydromorphone premedication in dogs.
Claude AK; Dedeaux A; Chiavaccini L; Hinz S
J Vet Intern Med; 2014; 28(5):1414-7. PubMed ID: 25146756
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Efficacy of Maropitant Versus Ondansetron in the Treatment of Dogs with Parvoviral Enteritis.
Sullivan LA; Lenberg JP; Boscan P; Hackett TB; Twedt DC
J Am Anim Hosp Assoc; 2018; 54(6):338-343. PubMed ID: 30272481
[TBL] [Abstract][Full Text] [Related]
17. The effect of maropitant on intraoperative isoflurane requirements and postoperative nausea and vomiting in dogs: a randomized clinical trial.
Swallow A; Rioja E; Elmer T; Dugdale A
Vet Anaesth Analg; 2017 Jul; 44(4):785-793. PubMed ID: 28844293
[TBL] [Abstract][Full Text] [Related]
18. A comparison between maropitant and metoclopramide for the prevention of morphine-induced nausea and vomiting in dogs.
Lorenzutti AM; Martín-Flores M; Litterio NJ; Himelfarb MA; Invaldi SH; Zarazaga MP
Can Vet J; 2017 Jan; 58(1):35-38. PubMed ID: 28042152
[TBL] [Abstract][Full Text] [Related]
19. Effects of maropitant in cats receiving dexmedetomidine and morphine.
Martin-Flores M; Sakai DM; Learn MM; Mastrocco A; Campoy L; Boesch JM; Gleed RD
J Am Vet Med Assoc; 2016 Jun; 248(11):1257-61. PubMed ID: 27172341
[TBL] [Abstract][Full Text] [Related]
20. Maropitant prevented vomiting but not gastroesophageal reflux in anesthetized dogs premedicated with acepromazine-hydromorphone.
Johnson RA
Vet Anaesth Analg; 2014 Jul; 41(4):406-10. PubMed ID: 24330310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
